Types of Insulin – insulin is safe in pregnancy
  Rapid-acting – for meals eaten at same time as injection 
  - Humalog (Lispro): 15-20mins/3-5 hours
- Novolog (Aspart): 10-20mins/3-5 hours
Short-acting – for meals eaten within 30-60mins 
  - Humulin or Novolin (Regular): 20-60mins/5-8 hours
- Velosulin: 30-60mins/2-3 hours
Intermediate-acting – half day or overnight (combo with rapid/short)
  - NPH: 1-2 hours/18-24 hours
- Lente: 1-2 hours/18-24 hours
Long-acting – about a full day (combo, if needed, with rapid/short)
  - Lantus (glargine): 1-1.5 hours/20-24 hours
- No peak time, delivered at a steady level
- Levemir/Detemir: 1-2 hours/up to 24 hours
- Peak time 6-8 hours
Pre-mixed – twice with meals 
  Oral Medications
  Actos (pioglitazone) – thiazolidinediones (^insulin sensitivity and secretion)
  - Maximum 45mg/day, Start 15-30mg/day
- ADR: liver problems (2.5x ULN)
- Contraindications: CHF III-IV (BBW)
- Well tolerated in older adults, don’t cause hypoglycemia, okay for renal dysfunction
Janumet (sitagliptin/metformin) – sitagliptin increases levels of incretin, decreases sugar from liver, metformin restores body’s response to insulin, decreases sugar from liver
  - Maximum 100/2000mg/day
Metformin – restores body’s response to insulin, decreases sugar from liver 
  - Contraindications: renal dysfunction (CHF?)
- Perks: has also been shown to decrease LDL and TC, weight loss, less hypoglycemia
- ADRs: GI, lactic acidosis (d/t OD or renal dysfunction)
Sulfonylureas (chlorpropamide, glyburide, glimepiride, glipizide) – increase insulin release
  - 1st and 2nd generations
- ADR: hypoglycemia, weight gain
Meglitinides (repaglinide and nateglinide) – similar to sulfonylureas 
  - If patient can’t use sulfonylureas, same weight gain as sulfonylureas, possibly less risk of hypoglycemia.
Alpha-glucosidase inhibitors (acarbose and miglitol) – block complex carbs to monosaccharides (slows glucose absorption)
  - ADR: GI very common
DDP-IV inhibitors (gliptins) – regulates enzymes involved with glycemic control 
  - No risk of hypoglycemia and weight-neutral (from UpToDate); however, safety of these drugs has not been established for long-term use. Also expensive, and need to be adjusted in renal insufficiency.
Subcutaneous Medications
  Byetta (Exenatide) - ^incretin to ^insulin
  - BID with breakfast and dinner, Abx/BC with lunch
- ADR: N/V/D/GI/decreased weight
- Contraindications: T1DM, Renal, Pancreatitis, pregnancy
Victoza (liraglutide) – increases insulin, decreases gastric emptying, decreases glucagon, GLP-1 analog 
  - BBW for thyroid tumor
- Another one in this class is exenatide, but it is BID injections (should not use with CrCl < 30ml/min)
 
No comments:
Post a Comment